Pricing and Market Access Director

Description The division carries two promoted rare disease assets in cystic fibrosis and pulmonary arterial hypertension, sitting on top of a wide base portfolio of trusted established medicines across Europe and a wider international footprint.

Growth comes from three places at once: defending and improving price and access on what we already own, unlocking value in markets where the portfolio is under monetised, and bringing in new assets through business development.

Own the commercial subst…